Lead Product(s): Padsevonil
Therapeutic Area: Neurology
Highest Development Status: Phase III Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 13, 2020
ARISE did not reach statistical significance for either of the two primary endpoints.